Literature DB >> 11502375

Infectious etiologies in acute exacerbation of COPD.

D Lieberman1, D Lieberman1, M Ben-Yaakov, Z Lazarovich, S Hoffman, B Ohana, M G Friedman, B Dvoskin, M Leinonen, I Boldur.   

Abstract

Acute exacerbation (AE) is a frequent episode during the prolonged chronic course of chronic obstructive pulmonary disease (COPD), which entails significant morbidity and mortality. The purpose of this study was to determine the frequency distribution of infectious etiologies in these episodes. Two hundred forty hospitalizations for AECOPD were included in a prospective, purely serologically based study. Paired sera were obtained for each of the hospitalizations and were tested using immunofluorescence or EIA methods to identify 13 different pathogens. Only significant changes in antibody titers were considered diagnostic. The mean age ( +/- SD) of the patients was 66.8 +/- 9.0 years and 179 (84%) were males. In 175 (72.9%) hospitalizations at least one infectious etiology was identified. In 117 (48.8%) hospitalizations at least one of 7 viral etiologies was identified. In 72 (30.0%) hospitalizations at least one of the following atypical bacteria was identified: Legionella spp. in 40 (16.7%), Mycoplasma pneumoniae in 34 (14.2%), and Coxiella burnetii in a single hospitalization. In 58 (24.2%) hospitalizations at least one classic bacterial etiology was found: Streptococcus pneumoniae in 48 (20.0%), Hemophilus influenzae in 10 (4.2%) and Moraxella catarrhalis in 9 (3.8%). More than one etiology was found in 72 (30.0%) hospitalizations. There were no significant differences in the etiologic distribution when the patients were classified by severity of airway obstruction or the clinical type of the exacerbation. We conclude that in most cases of hospitalization due to AECOPD the infectious etiology is viral or atypical bacteria and is classic bacteria in only a minority of cases. More than one etiologic cause can be identified in a third of the cases. The frequency distribution of the etiologies is not associated with the severity of airway obstruction or the clinical type of the exacerbation. The results of our study suggest that atypical bacteria should be covered in antibiotic regimens recommended for AECOPD. This issue should be addressed in future studies.

Entities:  

Mesh:

Year:  2001        PMID: 11502375     DOI: 10.1016/s0732-8893(01)00255-3

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  29 in total

1.  Application of loop-mediated isothermal amplification (LAMP) assay for the rapid diagnosis of pathogenic bacteria in clinical sputum specimens of acute exacerbation of COPD (AECOPD).

Authors:  Wei Zhang; Chuanhui Chen; Jian Cui; Wei Bai; Jing Zhou
Journal:  Int J Clin Exp Med       Date:  2015-05-15

Review 2.  COPD exacerbations . 2: aetiology.

Authors:  E Sapey; R A Stockley
Journal:  Thorax       Date:  2006-03       Impact factor: 9.139

3.  Comparison of diagnostic values of procalcitonin, C-reactive protein and blood neutrophil/lymphocyte ratio levels in predicting bacterial infection in hospitalized patients with acute exacerbations of COPD.

Authors:  Hakan Tanrıverdi; Tacettin Örnek; Fatma Erboy; Bülent Altınsoy; Fırat Uygur; Figen Atalay; Müge Meltem Tor
Journal:  Wien Klin Wochenschr       Date:  2015-01-14       Impact factor: 1.704

4.  Prevalence and clinical significance of fever in acute exacerbations of chronic obstructive pulmonary disease.

Authors:  D Lieberman; O Shmarkov; Y Gelfer; R Varshavsky; D V Lieberman
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-02-18       Impact factor: 3.267

5.  IL-23-dependent IL-17 production is essential in neutrophil recruitment and activity in mouse lung defense against respiratory Mycoplasma pneumoniae infection.

Authors:  Qun Wu; Richard J Martin; John G Rino; Rachel Breed; Raul M Torres; Hong Wei Chu
Journal:  Microbes Infect       Date:  2006-12-15       Impact factor: 2.700

6.  Chlamydophila pneumoniae re-infection triggers the production of IL-17A and IL-17E, important regulators of airway inflammation.

Authors:  Tímea Mosolygó; József Korcsik; Emese Petra Balogh; Ildikó Faludi; Dezső P Virók; Valéria Endrész; Katalin Burián
Journal:  Inflamm Res       Date:  2013-02-06       Impact factor: 4.575

Review 7.  Mycoplasma pneumoniae and its role as a human pathogen.

Authors:  Ken B Waites; Deborah F Talkington
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

Review 8.  Acute exacerbations and respiratory failure in chronic obstructive pulmonary disease.

Authors:  Neil MacIntyre; Yuh Chin Huang
Journal:  Proc Am Thorac Soc       Date:  2008-05-01

9.  Seroprevalence of Mycoplasma pneumoniae and Chlamydia pneumoniae in stable asthma and chronic obstructive pulmonary disease.

Authors:  Seoung-Ju Park; Yong-Chul Lee; Yang-Keun Rhee; Heung-Bum Lee
Journal:  J Korean Med Sci       Date:  2005-04       Impact factor: 2.153

Review 10.  Pathogen-directed therapy in acute exacerbations of chronic obstructive pulmonary disease.

Authors:  Fernando J Martinez
Journal:  Proc Am Thorac Soc       Date:  2007-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.